Low cholesterol levels cause specific negative health consequences
While large clinical trials confirm that lowering cholesterol via statins reduces cardiovascular events and mortality, observational studies highlight that spontaneously low cholesterol can be a marker of underlying illness, frailty, or elevated mortality risk in specific populations.
The claim touches on a nuanced area of medicine. While therapeutic cholesterol-lowering (e.g., via statins) is overwhelmingly proven to be safe and lifesaving (supported by major trials like [1] and [2]), epidemiological and acute-care studies (such as [10] and [11]) show that abnormally low cholesterol can accompany severe illness, frailty, infections, or increased mortality risk. Thus, low cholesterol is often a marker of underlying pathology or a complex prognostic indicator rather than a simple isolated cause of harm, placing the overall assessment in a contested category.
The evidence we hold leans leans refuted
How this was weighed
official record 3x · fact-check 2x · hedged 1x · crowd & reference 1x
- The Value of Serum Albumin and High‐Density Lipoprotein Chol · peer-reviewed · supports · weight 1.6 · 2001
- Following severe injury, hypocholesterolemia improves with c · peer-reviewed · supports · weight 1.6 · 2003
- Implications of Recent Clinical Trials for the National Chol · peer-reviewed · refutes · weight 3 · 2004
- Prevention of Cardiovascular Events and Death with Pravastat · peer-reviewed · refutes · weight 3 · 1998
Stefano Volpato, Suzanne G. Leveille, Maria‐Chiara Corti, Tamara B. Harris, Jack M. Guralnik. The Value of Serum Albumin and High‐Density Lipoprotein Cholesterol in Defining Mortality Risk in Older Persons with Low Serum Cholesterol. 2001. https://doi.org/10.1046/j.1532-5415.2001.49229.x
Study indicates that older individuals with low total cholesterol levels can exhibit elevated mortality risk, particularly when complicated by low albumin or other markers.
Scott M. Grundy, James I. Cleeman, C. Noel Bairey Merz, H Bryan Brewer, Luther T. Clark, Donald B. Hunninghake, Richard C. Pasternak, Sidney C. Smith, Neil J. Stone. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. 2004. https://doi.org/10.1161/01.cir.0000133317.49796.0e
Demonstrates that aggressive lowering of low-density lipoprotein cholesterol is safe and clinically beneficial in high-risk patients.
See more details
C. Michael Dunham, Michael Fealk, Wilbur E Sever. Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection. 2003. https://doi.org/10.1186/cc2382
Observes that persistent or worsening hypocholesterolemia correlates with severe outcomes such as organ failure and infection following traumatic injury.
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels. 1998. https://doi.org/10.1056/nejm199811053391902
Shows that therapeutic reduction of cholesterol levels using statins significantly decreases coronary and overall mortality without clinically significant adverse effects.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt